Vytrus Biotech, S.A. (BME:VYT)
Spain
· Delayed Price · Currency is EUR 5.50
0.00 (0.00%)
At close: Aug 15, 2025, 5:30 PM CET
Vytrus Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | 1.02 | 0.54 | 0.61 | 0.45 | 0.22 | Upgrade
|
| Depreciation & Amortization | 0.19 | 0.19 | 0.15 | 0.58 | 0.39 | Upgrade
|
| Other Amortization | 0.64 | 0.53 | 0.54 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.03 | Upgrade
|
| Other Operating Activities | -0.25 | -0.09 | 0.08 | -0.7 | -0.62 | Upgrade
|
| Change in Accounts Receivable | -0.08 | -0.11 | -0.22 | -0.06 | -0.06 | Upgrade
|
| Change in Inventory | 0.03 | -0.14 | -0.16 | -0.04 | -0.06 | Upgrade
|
| Change in Accounts Payable | 0.21 | -0.02 | 0.07 | 0.22 | 0.02 | Upgrade
|
| Change in Other Net Operating Assets | 0.09 | -0.01 | -0.05 | 0 | -0.05 | Upgrade
|
| Operating Cash Flow | 1.84 | 0.9 | 1.03 | 0.45 | -0.13 | Upgrade
|
| Operating Cash Flow Growth | 103.87% | -11.86% | 129.06% | - | - | Upgrade
|
| Capital Expenditures | -0.1 | -0.14 | -0.42 | -0.22 | -0.18 | Upgrade
|
| Cash Acquisitions | -0 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.1 | -1.02 | -0.87 | -0.05 | -0.05 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | 0 | - | - | Upgrade
|
| Investment in Securities | 0 | -0.02 | -0.03 | -0.03 | -0 | Upgrade
|
| Investing Cash Flow | -1.2 | -1.18 | -1.33 | -0.3 | -0.24 | Upgrade
|
| Long-Term Debt Issued | 0.2 | 1.65 | 0.38 | 0.27 | 0.86 | Upgrade
|
| Long-Term Debt Repaid | -0.61 | -0.68 | -0.35 | -0.27 | -0.19 | Upgrade
|
| Net Debt Issued (Repaid) | -0.41 | 0.96 | 0.03 | -0.01 | 0.67 | Upgrade
|
| Issuance of Common Stock | 1.29 | 0.12 | 0.17 | 0.25 | - | Upgrade
|
| Repurchase of Common Stock | -0.14 | -0.42 | -0.46 | -0.2 | -0.03 | Upgrade
|
| Other Financing Activities | 0.04 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 0.78 | 0.66 | -0.26 | 0.05 | 0.64 | Upgrade
|
| Net Cash Flow | 1.42 | 0.38 | -0.56 | 0.19 | 0.27 | Upgrade
|
| Free Cash Flow | 1.74 | 0.76 | 0.61 | 0.23 | -0.32 | Upgrade
|
| Free Cash Flow Growth | 128.46% | 25.94% | 166.43% | - | - | Upgrade
|
| Free Cash Flow Margin | 28.62% | 16.22% | 13.51% | 6.47% | -14.15% | Upgrade
|
| Free Cash Flow Per Share | 0.23 | 0.11 | - | 0.03 | -0.05 | Upgrade
|
| Cash Interest Paid | 0.09 | 0.1 | 0.06 | 0.08 | 0.06 | Upgrade
|
| Levered Free Cash Flow | 0.47 | -1.04 | -0.37 | 0.57 | 0.32 | Upgrade
|
| Unlevered Free Cash Flow | 0.55 | -0.94 | -0.24 | 0.64 | 0.4 | Upgrade
|
| Change in Working Capital | 0.24 | -0.27 | -0.36 | 0.12 | -0.15 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.